Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and ...
Secondary cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves overall survival in ...
Patients with desmoid tumors face significant clinical and economic burdens, impacting their quality of life and leading to ...
Nevada’s rapidly growing patient population is straining cardiovascular care capacity, leaving many patients without timely ...
Panelists discuss how prescription digital therapeutics can expand access to specialized mental health interventions in ...
Panelists discuss how future AML treatment will likely involve sophisticated decisions about triplet combinations, optimal ...
Advances in CAR T-cell therapy and bispecific antibodies have expanded treatment options, though access challenges remain. Medicaid expansion has enhanced cancer care in Louisiana, boosting access to ...
As pharmaceutical companies rapidly expand direct-to-consumer (DTC) models amid shifting US drug pricing reforms and the upcoming launch of TrumpRx, experts warn that these approaches introduce as ...
Clonal hematopoiesis of indeterminate potential (CHIP) subtypes, specifically non- DNMT3A genes, were associated with incident heart failure in older patients in a recent study published in JAMA ...
Osteoarthritis is more strongly associated with urge urinary incontinence, while rheumatoid arthritis is more linked to stress urinary incontinence. US adults with arthritis have higher odds of stress ...
Veterans in socioeconomically vulnerable areas and those experiencing homelessness face higher mortality risks during EHEs.
Today, the FDA approved durvalumab (Imfinzi; AstraZeneca) in combination with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy as a neoadjuvant and adjuvant treatment, followed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback